Ibogaine in the treatment of heroin withdrawal (Q34435912)

2 August 2017

1 reference

title

Ibogaine in the treatment of heroin withdrawal (English)

1 reference

2 August 2017

1 reference

Mash DC

1

1 reference

2 August 2017

Kovera CA

2

1 reference

2 August 2017

Pablo J

3

1 reference

2 August 2017

Tyndale R

4

1 reference

2 August 2017

Ervin FR

5

1 reference

2 August 2017

Kamlet JD

6

1 reference

2 August 2017

Hearn WL

7

1 reference

2 August 2017

publication date

1 January 2001

1 reference

The alkaloids. Chemistry and biology

2 August 2017

published in

1 reference

2 August 2017

volume

56

1 reference

2 August 2017

page(s)

155-171

1 reference

A preliminary investigation of ibogaine: case reports and recommendations for further study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Treatment of acute opioid withdrawal with ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Two New Rating Scales for Opiate Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

Indirect serotonergic agonists attenuate neuronal opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0099-9598%2801%2956012-5

7 January 2021

10.1016/S0099-9598(01)56012-5

Identifiers

DOI

1 reference

2 August 2017

1 reference